Testing effectiveness (Phase 2)UnknownNCT00044135
What this trial is testing
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Who this might be right for
Hepatitis B
Triangle Pharmaceuticals 30